Featured Communications 6

[FC6-2] α6GABA_A receptor-selective positive allosteric modulator as a novel therapy for ADHD: A preclinical study in MK-801-treated juvenile mice

*Lih-Chu Chiou^1,2, Chia-Chi Lu¹, Hsin-Jung Lee¹, Akihiro Mouri³, Dishary Sharmin⁵, James Cook⁵, Toshitaka Nabeshima⁴ (1. Graduate Institutue of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan, 2. Graduate Institutue of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan, 3. Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Graduate School of Health Sciences, Fujita Health University, Toyoake, Japan, 4. Laboratory of Health and Medical Science Innovation, Graduate School of Health Sciences, Fujita Health University, Toyoake, Japan, 5. Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.)

Keywords:ADHD, Cerebellum, GABA-A receptor